Prezista
Janssen eases HIV patent burden
December 3, 2012Sales and Marketing AIDS, Janssen, Prezista, darunavir
In a move which should appeal to public health campaigners, Janssen has declared that it will not enforce patents for …
HIV drug Prezista recalled on TBA contamination
May 17, 2011Manufacturing and Production HIV, Johnson & Johnson, Prezista, manufacturing and production, recalls
Johnson & Johnson has recalled 11,700 bottles of its HIV treatment Prezista after consumer reports of a mouldy smell caused …
Latest content
EnteroBiotix appoints former GSK Chief Medical Officer to board
November 3, 2026
AI: an early warning system for patient safety
November 3, 2026
